The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat

被引:18
|
作者
Paterson, Neil E.
Semenova, Svetlana [1 ]
Markou, Athina [1 ]
机构
[1] Univ Calif San Diego, Sch Med 0603, Dept Psychiat, La Jolla, CA 92093 USA
关键词
nicotine; withdrawal; self-administration; brain stimulation reward; somatic signs; desipramine; norepinephrine; rats;
D O I
10.1007/s00213-008-1144-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Nicotine withdrawal is characterized by depression-like symptomatology that may be mediated by dysregulations in norepinephrine transmission. These aversive aspects of nicotine withdrawal and the rewarding effects of nicotine play major roles in maintaining nicotine dependence. Objectives The aim of this work was to evaluate the effects of desipramine (DMI), a preferential norepinephrine reuptake inhibitor and antidepressant, on preclinical models of nicotine dependence in rats. Materials and methods A rate-independent current-intensity discrete-trial threshold intracranial self-stimulation procedure was used to assess brain reward function during nicotine withdrawal induced by cessation of nicotine infusion via subcutaneous osmotic mini pumps (3.16 mg/kg/day, base). Nicotine withdrawal was also measured by somatic signs of withdrawal. DMI was administered acutely (2 or 5 mg/kg, salt) during nicotine/saline withdrawal. In other naive rats, chronic DMI treatment via mini pump (15 mg/kg/day, salt) began after 7 days of nicotine/saline exposure and continued during administration of nicotine/saline for 14 days and during nicotine/saline withdrawal. Additional rats acquired intravenous nicotine- or food-maintained responding, were prepared with DMI/vehicle-containing mini pumps, and self-administered nicotine or food during 12 days of DMI/vehicle exposure. Results Acute DMI administration had no effect on threshold elevations observed in nicotine-withdrawing rats. Chronic DMI administration prevented the reward threshold elevations and the increased somatic signs of nicotine withdrawal. Although chronic DMI significantly decreased nicotine self-administration, it also decreased food-maintained responding. Conclusions The results suggest that norepinephrine reuptake inhibitors may be effective anti-smoking treatments that reduce the anhedonic depression-like and somatic components of nicotine withdrawal and may alter the rewarding effects of nicotine and food.
引用
收藏
页码:351 / 362
页数:12
相关论文
共 50 条
  • [41] The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers
    Barrett, Sean P.
    BEHAVIOURAL PHARMACOLOGY, 2010, 21 (02): : 144 - 152
  • [42] The Relative Impact of Acute Nicotine and Tobacco Administration on Craving, Withdrawal, and Cigarette Self-Administration in Dependent and Nondependent Smokers
    Spinella, Toni C.
    Barrett, Sean P.
    Schlagintweit, Hera E.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 29 (06) : 605 - 614
  • [43] Nicotine self-administration in rats: Strain and nicotine pre-exposure effects on acquisition
    Shoaib, M
    Schindler, CW
    Goldberg, SR
    PSYCHOPHARMACOLOGY, 1997, 129 (01) : 35 - 43
  • [44] Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition
    M. Shoaib
    Charles W. Schindler
    Steven R. Goldberg
    Psychopharmacology, 1997, 129 : 35 - 43
  • [45] Appetitive Pavlovian conditioning of the stimulus effects of nicotine enhances later nicotine self-administration
    Barrett, Scott T.
    Flynn, Allissa T.
    Huynh, Y. Wendy
    Bevins, Rick A.
    JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2022, 117 (03) : 543 - 559
  • [46] Nicotine self-administration in animals: A reevaluation
    Dar, R
    Frenk, H
    ADDICTION RESEARCH & THEORY, 2002, 10 (06) : 545 - 579
  • [47] Chronic caffeine exposure potentiates nicotine self-administration in rats
    M. Shoaib
    Long S. Swanner
    Sevil Yasar
    Steven R. Goldberg
    Psychopharmacology, 1999, 142 : 327 - 333
  • [48] Tranylcypromine enhancement of nicotine self-administration
    Villegier, Anne-Sophie
    Lotfipour, Shahrdad
    McQuown, Susan C.
    Belluzzi, James D.
    Leslie, Frances M.
    NEUROPHARMACOLOGY, 2007, 52 (06) : 1415 - 1425
  • [49] Cannabidiol as a potential cessation therapeutic: Effects on intravenous nicotine self-administration and withdrawal symptoms in mice
    Cheeks, Samantha N.
    Buzzi, Belle
    Valdez, Ashley
    Mogul, Allison S.
    Damaj, M. Imad
    Fowler, Christie D.
    NEUROPHARMACOLOGY, 2024, 246
  • [50] INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN THE BABOON
    ATOR, NA
    GRIFFITHS, RR
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 298 - 298